Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Morisset Valerie. Director active across 1 company, notably Eliem Therapeutics, Inc.. In total, 13 disclosures have been logged. Breakdown: 0 buy · 9 sells. Total volume traded: €1.7m. History available since 10 March 2023. The latest transaction was disclosed on 19 July 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Morisset Valerie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
10,201 shares@ US$7.093.9% of flowCommon StockSEC:0001415889-24-019946:0
50,000 shares@ US$7.2419.6% of flowCommon StockSEC:0001415889-24-019946:1
39,005 shares@ US$8.0717.0% of flowCommon StockSEC:0001415889-24-019946:2
30,000 shares@ US$7.9813.0% of flowCommon StockSEC:0001415889-24-019946:3
3,207 shares@ US$6.911.2% of flowCommon StockSEC:0001415889-24-019814:0
50,000 shares@ US$7.1319.3% of flowCommon StockSEC:0001415889-24-019706:0
50,000 shares@ US$7.0719.2% of flowCommon StockSEC:0001415889-24-019610:0
5,931 shares@ US$6.662.2% of flowCommon StockSEC:0001415889-24-019504:0
12,342 shares@ US$7.064.7% of flowCommon StockSEC:0001415889-24-019433:0
7,649 shares@ US$0.00020.0% of flowCommon StockSEC:0001415889-24-019147:0
17,847 shares@ US$0.00020.0% of flowCommon StockSEC:0001415889-24-010516:0
5,431 shares@ US$0.0020.0% of flowCommon StockSEC:0001415889-24-006211:0
255,219 shares@ US$0.0020.0% of flowCommon StockSEC:0001209191-23-018531:0
About Morisset Valerie
Morisset Valerie is a declarant linked to Eliem Therapeutics, Inc., where she holds the role of EVP, R&D AND CSO. She has filed 13 filings in total, and across the 13 sampled filings between 2023-03-14 and 2024-07-23, sales amount to EUR 1696790 and purchases amount to EUR 0.